Recent cancer survival in Germany: An analysis of common and less common cancers
Authors:
- Lina JansenLJLina Jansen
- Benjamin BarnesBBBenjamin Barnes
- Alexander KatalinicAKAlexander Katalinic
- Hermann BrennerHBHermann Brenner
- for the GEKID Cancer Survival Working GroupFGfor the GEKID Cancer Survival Working Group
- 26 November 2014
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 136 (11) , 2649-2658
Abstract
The monitoring of cancer survival by population‐based cancer registries is a prerequisite to evaluate the current quality of cancer care. Our study provides 1‐, 5‐ and 10‐year relative survival as well as 5‐year relative survival conditional on 1‐year survival estimates and recent survival trends for Germany using data from 11 population‐based cancer registries, covering around one‐third of the German population. Period analysis was used to estimate relative survival for 24 common and 11 less common cancer sites for the period 2007–2010. The German and the United States survival estimates were compared using the Surveillance, Epidemiology and End Results 13 database. Trends in cancer survival in Germany between 2002–2004 and 2008–2010 were described. Five‐year relative survival increased in Germany from 2002–2004 to 2008–2010 for most cancer sites. Among the 24 most common cancers, largest improvements were seen for multiple myeloma (8.0% units), non‐Hodgkin lymphoma (6.2% units), prostate cancer (5.2% units) and colorectal cancer (4.6% units). In 2007–2010, the survival disadvantage in Germany compared to the United States was largest for cancers of the mouth/pharynx (−11.0% units), thyroid (−6.8% units) and prostate (−7.5% units). Although survival estimates were much lower for elderly patients in both countries, differences in age patterns were observed for some cancer sites. The reported improvements in cancer survival might reflect advances in the quality of cancer care on the population level as well as increased use of screening in Germany. The survival differences across countries and the survival disadvantage in the elderly require further investigation.Keywords
Funding Information
- German Cancer Aid (108257 and 110446)
This publication has 33 references indexed in Scilit:
- Survival among adolescents and young adults with cancer in Germany and the United States: An international comparisonInternational Journal of Cancer, 2013
- Cancer survival in Eastern and Western Germany after the fall of the iron curtainEuropean Journal of Epidemiology, 2012
- Survival from colorectal cancer in Germany in the early 21st centuryBritish Journal of Cancer, 2012
- Survival for Ovarian Cancer in Europe: The across-country variation did not shrink in the past decadeActa Oncologica, 2012
- Deriving Valid Population–Based Cancer Survival Estimates in the Presence of Nonnegligible Proportions of Cancers Notified by Death Certificates OnlyCancer Epidemiology, Biomarkers & Prevention, 2011
- Socioeconomic inequalities in cancer survival in England after the NHS cancer planBritish Journal of Cancer, 2010
- How Does Older Age Influence Oncologists' Cancer Management?The Oncologist, 2010
- Improved survival in multiple myeloma and the impact of novel therapiesBlood, 2008
- Standard cancer patient population for age standardising survival ratiosEuropean Journal of Cancer, 2004
- Epidemiological aspects of cancer screening in GermanyJournal of Cancer Research and Clinical Oncology, 2003